The Blood Group Typing Market is gaining momentum as healthcare providers place greater emphasis on transfusion safety, accurate blood compatibility, and advanced diagnostic testing. Blood group typing is essential for identifying ABO and Rh blood groups before transfusions, surgeries, organ transplantation, and other procedures where blood compatibility is critical. According to Market Research Future, the global market was valued at USD 2.49 billion in 2024 and is projected to reach USD 6.37 billion by 2035, expanding at a CAGR of 8.9% during 2025–2035. Increasing blood donation activities, rising surgical volumes, organ transplantation, and growing awareness of transfusion-related complications are supporting market expansion. Automated testing is becoming increasingly important because laboratories can process larger sample volumes while reducing manual intervention and potential errors. Serological testing remains widely used, while molecular typing, microarray technologies, rapid testing, and next-generation sequencing are creating opportunities for more detailed blood-group identification.

North America remains a major regional market due to established blood-bank infrastructure, advanced healthcare facilities, and strong adoption of laboratory automation. Europe also represents a substantial market, while Asia-Pacific is expected to provide significant opportunities as healthcare infrastructure, blood donation programs, and diagnostic capabilities improve. Hospitals, blood banks, diagnostic laboratories, and research institutions are important end users. Product manufacturers are increasingly focusing on automated analyzers, reliable reagents, digital laboratory integration, and molecular diagnostic solutions. AI-assisted analysis could further improve workflow efficiency and interpretation of complex testing results. The expansion of portable blood-typing technologies may also support testing in remote locations and emergency environments. Despite opportunities, the industry faces challenges such as high costs for advanced equipment, shortages of trained professionals, and limited blood-service infrastructure in some developing regions. Nevertheless, increasing healthcare investment and the continuing requirement for safe transfusions are expected to support strong Market Growth through the forecast period.